Google
×
IRVINE, Calif., Dec. 29, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (Nasdaq: ELGX), developer and marketer of innovative treatments for aortic disorders, ...
Endologix, Inc. develops, manufactures, markets, and sells minimally invasive treatments for aortic disorders. Its flagship product, the Powerlink System, ...
Nov 6, 2019 · Investor Presentation. Page 2. SAFE HARBOR. 2. Forward-Looking Statements. This presentation ... Total ELGX. 63%. PRODUCT LEVEL. MARKET.
Missing: relations | Show results with:relations
Our common stock trades on the Nasdaq Global Select Market under the symbol “ELGX.” Holders. On March 4, 2020, there were 84 holders of record of our common ...
Guided by data, we pioneer interventions that address persistent unmet needs in patients with vascular disease. We empower physicians underserved by current ...
The Investor Relations website contains information about Eloxx Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial ...
People also ask
Forward-Looking Statements. This presentation includes statements that may be forward-looking statements within the meaning of the Private Securities.
Missing: relations | Show results with:relations
Investor Presentation May 4, 2017. Safe Harbor. Forward-Looking Statements This presentation includes statements that may be forward-looking statements.
Missing: relations | Show results with:relations
Endologix, Inc. ELGX, Q3 2010 Earnings Call, Oct ... investing and have earned very good returns for their stockholders and investors. ... 's website at www.
$0.22
Below are the latest news stories about Endologix Inc that investors may wish to consider to help them evaluate ELGX as an investment opportunity. Endologix ...
Missing: relations | Show results with:relations
Learn the direction Fisher Investments thinks the stock market could go and plan ahead. Have a $500k portfolio? Get the latest stock market outlook by Fisher Investments. Stocks. Stock Market Updates. Types of Stocks.